Quadrant Capital Group’s VivoSim Labs VIVS Stock Holding History

Quadrant Capital Group’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2	Closed	-$1K	–	2095
2017 Q1	$1K	Buy	+2	New	+$1.58K	﹤0.01%	1919

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Quadrant Capital Group's VIVS Position: Q2 2017 in Review

Quadrant Capital Group sold out of VivoSim Labs (VIVS) in Q2 2017, closing a stake of 2 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in VIVS in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

Quadrant Capital Group reported no remaining VivoSim Labs position as of Q2 2017 after selling out during the quarter.
Quadrant Capital Group sold 2 VivoSim Labs shares in Q2 2017, an estimated $1K.
Quadrant Capital Group first reported a position in VivoSim Labs in Q1 2017 and held it in 1 quarter.
Quadrant Capital Group's VivoSim Labs position peaked at $1K in Q1 2017.
117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Quadrant Capital Group's 13F filing for Q2 2017, filed 15 Aug 2017.